Histamine H ₃ receptor antagonists/inverse agonists: a patent review (October 2017- December 2023) documenting progress

Expert Opinion on Therapeutic Patents, Год журнала: 2024, Номер unknown, С. 1 - 25

Опубликована: Дек. 31, 2024

Histamine H3 receptor antagonists/inverse agonists, since the discovery of histamine (H3R), are important ligands in search for new potential drugs. The most interesting CNS diseases as these receptors mainly there preseant.

Язык: Английский